Review



apoptotic changes  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress apoptotic changes
    Apoptotic Changes, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/apoptotic changes/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    apoptotic changes - by Bioz Stars, 2026-05
    94/100 stars

    Images



    Similar Products

    94
    MedChemExpress apoptotic changes
    Apoptotic Changes, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/apoptotic changes/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    apoptotic changes - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    90
    Proimmune proimmune/pro-apoptotic versus anti-immune/anti-apoptotic genetic change summary
    Proimmune/Pro Apoptotic Versus Anti Immune/Anti Apoptotic Genetic Change Summary, supplied by Proimmune, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/proimmune/pro-apoptotic versus anti-immune/anti-apoptotic genetic change summary/product/Proimmune
    Average 90 stars, based on 1 article reviews
    proimmune/pro-apoptotic versus anti-immune/anti-apoptotic genetic change summary - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    93
    Selleck Chemicals apoptotic changes
    Apoptotic Changes, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/apoptotic changes/product/Selleck Chemicals
    Average 93 stars, based on 1 article reviews
    apoptotic changes - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    99
    Beyotime apoptotic morphology analysis apoptotic morphological changes
    Apoptotic Morphology Analysis Apoptotic Morphological Changes, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/apoptotic morphology analysis apoptotic morphological changes/product/Beyotime
    Average 99 stars, based on 1 article reviews
    apoptotic morphology analysis apoptotic morphological changes - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    97
    Beyotime characteristic apoptotic morphological changes
    Arenobufagin induces caspase-dependent apoptosis in non-small-cell lung cancer (NSCLC) cells. ( A ) A549 and NCI-H460 cells were treated with the indicated concentrations of arenobufagin for 24 h, and <t>apoptotic</t> morphological changes were evaluated by Hoechst 33258 staining; ( B , C ) A549 and NCI-H460 cells were treated with arenobufagin at the indicated concentrations for 24 h, and protein extracts were subjected to Western blot assay with indicated antibodies; ( D , E ) A549 cells were pre-treated with the caspase inhibitor Z-VAD (40 μΜ) for 1 h, followed by incubation with arenobufagin (Are, 25 nM) for 24 h; ( D ) poly (ADP-ribose) polymerase (PARP) cleavage was analyzed by Western blotting; ( E ) The cell viability was detected via trypan blue exclusion assay. ** p < 0.01, arenobufagin-treated group versus arenobufagin and Z-VAD combination group.
    Characteristic Apoptotic Morphological Changes, supplied by Beyotime, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/characteristic apoptotic morphological changes/product/Beyotime
    Average 97 stars, based on 1 article reviews
    characteristic apoptotic morphological changes - by Bioz Stars, 2026-05
    97/100 stars
      Buy from Supplier

    97
    Beyotime apoptotic morphological changes
    Arenobufagin induces caspase-dependent apoptosis in non-small-cell lung cancer (NSCLC) cells. ( A ) A549 and NCI-H460 cells were treated with the indicated concentrations of arenobufagin for 24 h, and <t>apoptotic</t> morphological changes were evaluated by Hoechst 33258 staining; ( B , C ) A549 and NCI-H460 cells were treated with arenobufagin at the indicated concentrations for 24 h, and protein extracts were subjected to Western blot assay with indicated antibodies; ( D , E ) A549 cells were pre-treated with the caspase inhibitor Z-VAD (40 μΜ) for 1 h, followed by incubation with arenobufagin (Are, 25 nM) for 24 h; ( D ) poly (ADP-ribose) polymerase (PARP) cleavage was analyzed by Western blotting; ( E ) The cell viability was detected via trypan blue exclusion assay. ** p < 0.01, arenobufagin-treated group versus arenobufagin and Z-VAD combination group.
    Apoptotic Morphological Changes, supplied by Beyotime, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/apoptotic morphological changes/product/Beyotime
    Average 97 stars, based on 1 article reviews
    apoptotic morphological changes - by Bioz Stars, 2026-05
    97/100 stars
      Buy from Supplier

    Image Search Results


    Arenobufagin induces caspase-dependent apoptosis in non-small-cell lung cancer (NSCLC) cells. ( A ) A549 and NCI-H460 cells were treated with the indicated concentrations of arenobufagin for 24 h, and apoptotic morphological changes were evaluated by Hoechst 33258 staining; ( B , C ) A549 and NCI-H460 cells were treated with arenobufagin at the indicated concentrations for 24 h, and protein extracts were subjected to Western blot assay with indicated antibodies; ( D , E ) A549 cells were pre-treated with the caspase inhibitor Z-VAD (40 μΜ) for 1 h, followed by incubation with arenobufagin (Are, 25 nM) for 24 h; ( D ) poly (ADP-ribose) polymerase (PARP) cleavage was analyzed by Western blotting; ( E ) The cell viability was detected via trypan blue exclusion assay. ** p < 0.01, arenobufagin-treated group versus arenobufagin and Z-VAD combination group.

    Journal: Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry

    Article Title: Arenobufagin Induces Apoptotic Cell Death in Human Non-Small-Cell Lung Cancer Cells via the Noxa-Related Pathway

    doi: 10.3390/molecules22091525

    Figure Lengend Snippet: Arenobufagin induces caspase-dependent apoptosis in non-small-cell lung cancer (NSCLC) cells. ( A ) A549 and NCI-H460 cells were treated with the indicated concentrations of arenobufagin for 24 h, and apoptotic morphological changes were evaluated by Hoechst 33258 staining; ( B , C ) A549 and NCI-H460 cells were treated with arenobufagin at the indicated concentrations for 24 h, and protein extracts were subjected to Western blot assay with indicated antibodies; ( D , E ) A549 cells were pre-treated with the caspase inhibitor Z-VAD (40 μΜ) for 1 h, followed by incubation with arenobufagin (Are, 25 nM) for 24 h; ( D ) poly (ADP-ribose) polymerase (PARP) cleavage was analyzed by Western blotting; ( E ) The cell viability was detected via trypan blue exclusion assay. ** p < 0.01, arenobufagin-treated group versus arenobufagin and Z-VAD combination group.

    Article Snippet: Characteristic apoptotic morphological changes were assessed by Hoechst 33258 staining, using the Hoechst staining kit (Beyotime, Haimen, China).

    Techniques: Staining, Western Blot, Incubation, Trypan Blue Exclusion Assay